老虎證券

美股詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Aurinia Pharmaceuticals Inc

16.41
+0.31001.93%
盤後：16.410.00000.00%19:30 EDT
成交量：75.35萬
成交額：1,228.64萬
市值：21.83億
市盈率：7.12
高：16.52
開：16.03
低：15.93
收：16.10
52周最高：19.25
52周最低：10.34
股本：1.33億
流通股本：1.29億
量比：1.03
換手率：0.58%
股息：- -
股息率：- -
每股收益(TTM):2.30
每股收益(LYR):2.07
淨資產收益率：66.12%
總資產收益率：15.49%
市淨率：3.55
市盈率(LYR):7.93

資料載入中...

總覽公司新聞資訊公告
2020/06/09

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2020/03/19

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/17

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/16

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/12

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/03/05

年度報告

Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]
2020/03/05

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/25

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2020/02/14

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/13

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/07

超過5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/01/27

超過5%披露

Statement of acquisition of beneficial ownership by individuals
2019/12/18

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/12/18

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/12

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/10

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/12/10

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/09

非美公司披露報告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/12/09

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/12/06

超過5%披露

[Amend] General statement of acquisition of beneficial ownership
更多